(JPost) A small team of Israeli scientists think they might have found the first complete cure for cancer.

“We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, of a new treatment being developed by his company, Accelerated Evolution Biotechnologies Ltd. (AEBi), which was founded in 2000 in the ITEK incubator in the Weizmann Science Park.

“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side effects at a much lower cost than most other treatments on the market,” Aridor said. “Our solution will be both generic and personal.”

Aridor, chairman of the board of AEBi, and CEO Dr. Ilan Morad, say their treatment, which they call MuTaTo (multi-target toxin) is essentially on the scale of a cancer antibiotic—a disruption technology of the highest order.

Morad equated the concept of MuTaTo to the triple drug cocktail that has helped change AIDS from being an automatic death sentence to a chronic—but often manageable—disease.